[{"address1": "The Omeros Building", "address2": "201 Elliott Avenue West", "city": "Seattle", "state": "WA", "zip": "98119", "country": "United States", "phone": "206 676 5000", "website": "https://www.omeros.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; zaltenibart that is in phase 3 clinical trials for Paroxysmal nocturnal hemoglobinuria; in phase 2 clinical trial for the treatment complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Immunostimulator Combination Therapies, and Oncotoxins and Immunomodulators for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.", "fullTimeEmployees": 202, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gregory A. Demopulos M.D.", "age": 65, "title": "Co-Founder, Chairman, CEO & President", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 5965279, "exercisedValue": 0, "unexercisedValue": 39325}, {"maxAge": 1, "name": "Mr. Peter B. Cancelmo J.D.", "age": 45, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 611435, "exercisedValue": 0, "unexercisedValue": 5500}, {"maxAge": 1, "name": "Dr. Pamela Pierce Palmer M.D., Ph.D.", "age": 61, "title": "Co-Founder", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David J. Borges", "age": 59, "title": "VP of Finance, Chief Accounting Officer & Treasurer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. George A. Gaitanaris M.D., Ph.D.", "age": 67, "title": "Chief Scientific Officer & VP of Science", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter W. Williams", "age": 56, "title": "Vice President of Human Resources", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Catherine A. Melfi Ph.D.", "age": 65, "title": "Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nadia  Dac", "age": 54, "title": "VP & Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andreas  Grauer M.D.", "age": 63, "title": "VP & Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David W. Ghesquiere", "age": 57, "title": "VP & Chief Business Development Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.3, "open": 7.3, "dayLow": 7.1, "dayHigh": 7.48, "regularMarketPreviousClose": 7.3, "regularMarketOpen": 7.3, "regularMarketDayLow": 7.1, "regularMarketDayHigh": 7.48, "payoutRatio": 0.0, "beta": 2.355, "forwardPE": -3.1239316, "volume": 367571, "regularMarketVolume": 367571, "averageVolume": 616431, "averageVolume10days": 540690, "averageDailyVolume10Day": 540690, "bid": 5.26, "ask": 9.2, "bidSize": 2, "askSize": 2, "marketCap": 424447104, "fiftyTwoWeekLow": 3.0, "fiftyTwoWeekHigh": 13.6, "fiftyDayAverage": 7.9796, "twoHundredDayAverage": 6.7192, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 757592128, "profitMargins": 0.0, "floatShares": 55488186, "sharesOutstanding": 58063900, "sharesShort": 9326578, "sharesShortPriorMonth": 9225776, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.16059999, "heldPercentInsiders": 0.044359997, "heldPercentInstitutions": 0.46209, "shortRatio": 17.97, "shortPercentOfFloat": 0.168, "impliedSharesOutstanding": 58063900, "bookValue": -3.146, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -182628992, "trailingEps": -3.14, "forwardEps": -2.34, "enterpriseToEbitda": -4.501, "52WeekChange": 1.3354633, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 7.31, "targetHighPrice": 36.0, "targetLowPrice": 36.0, "targetMeanPrice": 36.0, "targetMedianPrice": 36.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 90132000, "totalCashPerShare": 1.552, "ebitda": -168308000, "totalDebt": 423276992, "quickRatio": 1.231, "currentRatio": 1.686, "returnOnAssets": -0.32284, "grossProfits": -71549000, "freeCashflow": -114679128, "operatingCashflow": -148803008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OMER", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Omeros Corporation", "longName": "Omeros Corporation", "postMarketChangePercent": -3.00957, "postMarketPrice": 7.09, "postMarketChange": -0.22, "regularMarketChange": 0.009999752, "regularMarketDayRange": "7.1 - 7.48", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 616431, "fiftyTwoWeekLowChange": 4.31, "fiftyTwoWeekLowChangePercent": 1.4366666, "fiftyTwoWeekRange": "3.0 - 13.6", "fiftyTwoWeekHighChange": -6.2900004, "fiftyTwoWeekHighChangePercent": -0.4625, "fiftyTwoWeekChangePercent": 133.54633, "earningsTimestamp": 1743451320, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.14, "epsForward": -2.34, "epsCurrentYear": -2.27667, "priceEpsCurrentYear": -3.21083, "fiftyDayAverageChange": -0.6696, "fiftyDayAverageChangePercent": -0.08391398, "twoHundredDayAverageChange": 0.5907998, "twoHundredDayAverageChangePercent": 0.0879271, "priceToBook": -2.3235855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1255008600000, "corporateActions": [], "postMarketTime": 1745613214, "regularMarketTime": 1745611201, "exchange": "NGM", "messageBoardId": "finmb_32388", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.1369829, "regularMarketPrice": 7.31, "displayName": "Omeros", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]